Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Damian McNeil

Deutsche Bank · covers Consumer Defensive

Period: Reporting periods mapped to calendar 2025 Q2 – 2026 Q2 (5 quarters).

Limited coverage. Only 7 questions of coverage. Treat these numbers as directional — sample too small for reliable averages.
Questions
7on tracked calls
Challenge rate
0%none of 7 questionsLimited sample
Companies
2questioned at least once
Reporting periods
5with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 7 of 7 questions from 2 companies

MOAltria4 questions · 4 reporting periods · 0 of 4 challenging
MO company page →

Calendar 2026 Q2

is there anything that you're doing with the regular on! products to sort of support or strengthen

Product LaunchInnovation & R&DTranscript · FY2026 Q2 →
Show response

Committed to continued on! classic innovation and framed the two products as complementary, but gave no timing for a return to e-vapor.

Calendar 2026 Q1

Can you just sort of give an indication of where that shelf space is coming from?

Competitive DynamicsProduct LaunchTranscript · FY2026 Q1 →
Show response

Gifford gave a high-level answer, framing nicotine pouches as their own retail category, without specifying which products ceded the space.

Calendar 2025 Q4

can you clarify or confirm that this 30,000 stores that you've targeted is kind of the ceiling

Competitive DynamicsPricingTranscript · FY2025 Q4 →
Show response

Billy confirmed roughly 30,000 stores with potential fringe adjustments. Will adapt promotions as economic conditions change. Sal noted import-export payback is less than a year.

Calendar 2025 Q2

whether you can sort of provide any color on what your plans after second half in terms of whether you're expecting to accelerate activation

Product LaunchCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Billy was careful not to reveal competitive plans but noted first half success is sustainable. Focused on equity building and pipeline products.

PMPhilip Morris International3 questions · 2 reporting periods · 0 of 3 challenging
PM company page →

Calendar 2025 Q4

Just wondering whether you're in a position to quantify whether we should expect a similar level of cost savings, for the medium-term guidance at the '28. And what scope AI may have to accelerate c...

MarginInnovation & R&DTranscript · FY2025 Q4 →
Show response

Emmanuel confirmed ambition for continued cost efficiency split roughly 60% COGS / 40% back-office but declined to quantify the medium-term target, noting AI as a future efficiency driver while describing it as a sensitive topic.

Calendar 2025 Q3

what do you see as the sort of a long-term sustainable price premium falls in in The U.S, please?

PricingCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Emmanuel declined to quantify the premium target but affirmed ZYN's franchise strength justifies 'a very nice premium' that they intend to maintain.

Just what degree of visibility do you have on the inventory adjustment that you're expecting in Q4 What's the confidence behind that?

Supply ChainGuidance ReliabilityTranscript · FY2025 Q3 →
Show response

Emmanuel detailed IQOS expects ~2B stick Q4 adjustment with shipments potentially below IMS. ZYN expects 20-30M can reduction delayed from Q3 by September promotions, but acknowledged uncertainty on Q4 timing.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
MO Altria40%none of 4 questions
PM Philip Morris International30%none of 3 questions
  • MO
    Altria · 4 questions
    0%none of 4 questions
  • PM
    Philip Morris International · 3 questions
    0%none of 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2025 Q210%none of 1 question1
2025 Q320%none of 2 questions1
2025 Q420%none of 2 questions2
2026 Q110%none of 1 question1
2026 Q210%none of 1 question1
  1. 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2025 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
  3. 2025 Q42 questions · challenge rate 0% (none of 2 questions) · 2 companies
  4. 2026 Q11 question · challenge rate 0% (none of 1 question) · 1 company
  5. 2026 Q21 question · challenge rate 0% (none of 1 question) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Competitive Dynamics4
  • Product Launch3
  • Innovation & R&D2
  • Pricing2
  • Margin1
  • Supply Chain1
  • Guidance Reliability1